Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Br J Dermatol ; 180(2): 289-296, 2019 02.
Artículo en Inglés | MEDLINE | ID: mdl-29947134

RESUMEN

BACKGROUND: Bakuchiol is a phytochemical that has demonstrated cutaneous antiageing effects when applied topically. Early studies have suggested that bakuchiol is a functional analogue of topical retinoids, as both compounds have been shown to induce similar gene expression in the skin and lead to improvement of cutaneous photodamage. No in vivo studies have compared the two compounds for efficacy and side-effects. OBJECTIVES: To compare the clinical efficacy and side-effect profiles of bakuchiol and retinol in improving common signs of cutaneous facial ageing. METHODS: This was a randomized, double-blind, 12-week study in which 44 patients were asked to apply either bakuchiol 0·5% cream twice daily or retinol 0·5% cream daily. A facial photograph and analytical system was used to obtain and analyse high-resolution photographs of patients at 0, 4, 8 and 12 weeks. Patients also completed tolerability assessment questions to review side-effects. During study visits, a board-certified dermatologist, blinded to study group assignments, graded pigmentation and redness. RESULTS: Bakuchiol and retinol both significantly decreased wrinkle surface area and hyperpigmentation, with no statistical difference between the compounds. The retinol users reported more facial skin scaling and stinging. CONCLUSIONS: Our study demonstrates that bakuchiol is comparable with retinol in its ability to improve photoageing and is better tolerated than retinol. Bakuchiol is promising as a more tolerable alternative to retinol.


Asunto(s)
Fenoles/administración & dosificación , Envejecimiento de la Piel/efectos de los fármacos , Luz Solar/efectos adversos , Vitamina A/administración & dosificación , Adulto , Método Doble Ciego , Cara , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dolor/inducido químicamente , Dolor/epidemiología , Dimensión del Dolor , Fenoles/efectos adversos , Estudios Prospectivos , Piel/efectos de los fármacos , Piel/efectos de la radiación , Envejecimiento de la Piel/efectos de la radiación , Crema para la Piel/administración & dosificación , Crema para la Piel/efectos adversos , Pigmentación de la Piel/efectos de los fármacos , Pigmentación de la Piel/efectos de la radiación , Resultado del Tratamiento , Vitamina A/efectos adversos
2.
Br J Cancer ; 68(4): 678-80, 1993 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8398692

RESUMEN

Antimetabolites are S-phase specific anticancer drugs. Administration of bromodeoxyuridine (BrdUrd) to tumour bearing mice was followed by treatment with cytosine arabinoside or hydroxyurea. Anti-BrdUrd immunocytochemistry visualised susceptible tumour and intestinal crypt cells at electron microscope level, showing unequivocally that cells that were in S-phase at the time of administration of the drugs subsequently died by apoptosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Carcinoma/patología , Citarabina/farmacología , Hidroxiurea/farmacología , Intestino Delgado/patología , Fase S , Sarcoma Experimental/patología , Animales , Apoptosis/fisiología , Bromodesoxiuridina , Carcinoma/tratamiento farmacológico , Intestino Delgado/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos CBA , Índice Mitótico/efectos de los fármacos , Sarcoma Experimental/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA